miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1

Biochemical and Biophysical Research Communications

Volumn 457, Issue 2, 2015, Pages 125-132

  Wan, Lu Ying ^a   Deng, Jun ^a   Xiang, Xiao Jun ^a   Zhang, Ling ^a   Yu, Feng ^a   Chen, Jun ^a   Sun, Zhe ^a   Feng, Miao ^a   Xiong, Jian Ping ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Chemo resistance; Colon cancer; FOXM1; miR 320; Wnt

Indexed keywords

BETA CATENIN; FLUOROURACIL; MICRORNA; MICRORNA 320; OXALIPLATIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; MIRN320 MICRORNA, HUMAN; PLATINUM COMPLEX;

ARTICLE; CANCER CELL; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; CHEMORADIOTHERAPY; COLON CANCER; DRUG HYPERSENSITIVITY; GENE TARGETING; HCT116 CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MULTIMODALITY CANCER THERAPY; ONCOGENE; ONCOGENE FOXM1; PRIORITY JOURNAL; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; 3' UNTRANSLATED REGION; APOPTOSIS; CELL CYCLE; CELL MOTION; COLONIC NEOPLASMS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR INVASION;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CHEMORADIOTHERAPY; COLONIC NEOPLASMS; FLUOROURACIL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; ORGANOPLATINUM COMPOUNDS;

EID: 84921774879     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.039     Document Type: Article

References (22)

1. M. Halasi, A.L. Gartel, FOX(M1) news - it is cancer, Mol. Cancer Ther. 12 (2013) 245-254.
2. M. Quan, P. Wang, J. Cui, et al., The roles of FOXM1 in pancreatic stem cells and carcinogenesis, Mol. Cancer 12 (2013) 159.
3. D. Li, P. Wei, Z. Peng, et al., The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis, Clin. Cancer Res. 19 (2013) 62-72.
4. N. Zhang, X. Wu, L. Yang, et al., FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51, Clin. Cancer Res. 18 (2012) 5961-5971.
5. J.M. Kwok, B. Peck, L.J. Monteiro, et al., FOXM1 confers acquired cisplatin resistance in breast cancer cells, Mol. Cancer Res. 8 (2010) 24-34.
6. Y. Yoshida, I.C. Wang, H.M. Yoder, et al., The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer, Gastroenterology 132 (2007) 1420-1431.
7. F. Zhao, E.W. Lam, Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance, Front. Med. 6 (2012) 376-380.
8. V. Lopes-Rodrigues, H. Seca, D. Sousa, et al., The network of P-glycoprotein and microRNAs interactions, Int. J. Cancer 135 (2014) 253-263.
9. Y. Zhang, X. He, Y. Liu, et al., MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer, Oncol. Rep. 27 (2012) 685-694.
10. J.Y. Sun, Y. Huang, J.P. Li, X. Zhang, et al., MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin, Biochem. Biophys. Res. Commun. 420 (2012) 787-792.
11. H. Zhao, T. Dong, H. Zhou, et al., MiR-320a suppresses colorectal cancer progression by targeting Rac1, Carcinogenesis 35 (2014) 886-895.
12. I.S. Hsieh, K.C. Chang, Y.T. Tsai, et al., MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway, Carcinogenesis 34 (2013) 530-538.
13. L. Chen, H.X. Yan, W. Yang, et al., The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma, J. Hepatol. 50 (2009) 358-369.
14. F. Meng, R. Henson, M. Lang, et al., Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines, Gastroenterology 130 (2006) 2113-2129.
15. J. Salendo, M. Spitzner, F. Kramer, et al., Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g, Radiother. Oncol. 108 (2013) 451-457.
16. D. Ziliak, E.R. Gamazon, B. Lacroix, et al., Genetic variation that predicts platinum sensitivity reveals the role of miR-193b∗ in chemotherapeutic susceptibility, Mol. Cancer Ther. 11 (2012) 2054-2061.
17. P. Khongkow, U. Karunarathna, M. Khongkow, et al., FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance, Oncogene (2013).
18. Y. Wang, L. Wen, S.H. Zhao, et al., FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients, Lung Cancer 79 (2013) 173-179.
19. J. Li, Y. Wang, J. Luo, et al., MiR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells, FEBS Lett. 586 (2012) 3761-3765.
20. Y. Ke, W. Zhao, J. Xiong, et al., MiR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1, Biochem. Res. Int. 2013 (2013) 506731.
21. X. Zhang, J. Zeng, M. Zhou, et al., The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia, Mol. Cancer 11 (2012) 56.
22. M. Kahn, Can we safely target the WNT pathway?, Nat Rev. Drug Discov. 13 (2014) 513-532.